Traduction de «falls in older people » (Néerlandais → Français) :

Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database of Systematic Revieuws, (2), p.CD005465.
Interventions for preventing falls in older people in nursing care facilities and hospitals.

Bespreking van : Thomas S, Mackintosh S, Halbert J. Does the 'Otago exercise programme' reduce mortality and falls in older adults?: a systematic review and meta-analysis.
Analyse de : Thomas S, Mackintosh S, Halbert J. Does the 'Otago exercise programme' reduce mortality and falls in older adults?: a systematic review and meta-analysis.

11. Jensen J, Lundin-Olsson L, et al. Fall and injury prevention in older
11. Jensen J, Lundin-Olsson L, et al. Fall and injury prevention in older people

Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions.
Influenza vaccination for healthcare workers who care for people aged 60 or older living in longterm care institutions.

Thus, whereas young people are far more inclined to attempt to commit suicide, attempted suicides have a considerably more frequently fatal outcome amongst older individuals.
Ainsi, si les jeunes sont beaucoup plus enclins à tenter de se suicider, les tentatives de suicide sont nettement plus souvent fatales chez les individus plus âgés.

Ilaris (ACZ885) (USD 6 million), is the first medicine to treat adults and children aged four years and older suffering cryopyrin-associated periodic syndrome (CAPS), a group of rare autoinflammatory disorders that affect one in one million people.
Ilaris (ACZ885) (USD 6 million), est le premier médicament pour traiter les adultes et les enfants de plus de quatre ans souffrant du syndrome périodique associé à la cryopirine (CAPS), un groupe de maladies auto-inflammatoires qui touche une personne sur un million.

Ilaris (ACZ885, canakinumab) (USD 6 million) is a biologic medicine approved in more than 40 countries to treat adults and children aged four years and older suffering from cryopyrin-associated periodic syndrome (CAPS), a group of rare auto-inflammatory disorders that affect approximately one in one million people.
Ilaris (ACZ885, canakinumab) (USD 6 millions), est un médicament biologique autorisé dans plus de quarante pays pour traiter les adultes et les enfants de plus de quatre ans souffrant du syndrome périodique associé à la cryopirine (CAPS), un groupe de maladies auto-inflammatoires qui touche environ une personne sur un million.